Document is current
Any future updates will be listed below
-
Authors
Liu, Jun https://orcid.org/0000-0001-5040-8344
Wang, Li https://orcid.org/0000-0001-9580-2476
Kurtesi, Alexandra
Budylowski, Patrick
Potts, Kyle G.
Menon, Haritha
Tan, Yilin
Samaan, Philip
Liu, Xinan
Wang, Yisen
Hu, Queenie
Samson, Reuben https://orcid.org/0009-0005-8965-3212
Qi, Freda
Evseev, Danyel
John, Cini
Ellestad, Kristofor K.
Fan, Yue
Budiman, Frans
Tohan, Ellaine Riczly
Udayakumar, Suji
Yang, Jennifer
Marcusson, Eric G.
Gingras, Anne-Claude
Mahoney, Douglas J.
Ostrowski, Mario A.
Martin-Orozco, Natalia
-
Funding
Funding for this research was provided by:
Ontario Graduate Scholarship
Gouvernement du Canada | Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 4 April 2024
Accepted: 2 January 2025
First Online: 10 January 2025
Competing interests
: A-CG, DJM, MAO receive funds from a research contract with Providence Therapeutics Holdings, Inc. JL, HM, YT, EGM, NM-O are employees of Providence Therapeutics Holdings, Inc. LW, XL, YW, YF, JY are employees of Everest Medicines. EGM and NM-O are inventors on a patent application related to this work filed by Providence Therapeutics Holdings, Inc. (NO. CA3096009, Filed Oct 9, 2020). These authors declare no other financial or non-financial competing interests. All other authors declare no financial or non-financial competing interests.
